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Abstract
Background: Piper sarmentosum, locally known as kaduk is belonging to the family of Piperaceae.
It is our interest to evaluate their effect on human hepatoma cell line (HepG2) for the potential of
anticarcinogenic activity.
Results: The anticarcinogenic activity of an ethanolic extract from Piper sarmentosum in HepG2
and non-malignant Chang's liver cell lines has been previously determined using (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) (MTT) assays, where the IC50 value was
used as a parameter for cytotoxicity. The ethanolic extract that showed anticarcinogenic
properties in HepG2 cells had an IC50 of 12.5 μg mL-1, while IC50 values in the non-malignant
Chang's liver cell line were greater than 30 μg mL-1. Apoptotic morphological changes in HepG2
cells were observed using an inverted microscope and showed chromatin condensation, cell
shrinkage and apoptotic bodies following May-Grunwald-Giemsa's staining. The percentage of
apoptotic cells in the overall population (apoptoti c  i n d e x )  s h o w e d  a  c o ntinuously significant
increase (p < 0.05) in 12.5 μg mL-1 ethanolic extract-treated cells at 24, 48 and 72 hours compared
to controls (untreated cells). Following acridine orange and ethidium bromide staining, treatment
with 10, 12 and 14 μg mL-1 of ethanolic extracts caused typical apoptotic morphological changes in
HepG2 cells. Molecular analysis of DNA fragmentation was used to examine intrinsic apoptosis
induced by the ethanolic extracts. These results showed a typical intrinsic apoptotic
characterisation, which included fragmentation of nuclear DNA in ethanolic extract-treated
HepG2 cells. However, the non-malignant Chang's liver cell line produced no DNA fragmentation.
In addition, the DNA genome was similarly intact for both the untreated non-malignant Chang's
liver and HepG2 cell lines.
Conclusion:  Therefore, our results suggest that the ethanolic extract from P. sarmentosum
induced anticarcinogenic activity through an intrinsic apoptosis pathway in HepG2 cells in vitro.
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Background
Human hepatocellular carcinoma is the fifth most com-
mon cancer in the world and the fourth most common
cause of cancer-associated mortality [1]. Surgical resection
and local treatment are frequently limited due to metasta-
sis, cirrhosis, and other pathological changes in the liver
parenchyma. The synchronous occurrence of human
hepatocellular carcinoma may be due to different risk fac-
tors such as chronic viral hepatitis B or hepatitis C infec-
tion, aflotoxin explosure, alcohol consumption and iron
overload [2]. The development of chemotherapeutic or
chemopreventive agents for hepatocellular carcinoma is
important in order to help reduce the mortality caused by
this disease [3]. Thus, significant research efforts have
focused on novel chemotherapeutic drugs from the plant
kingdom in search of cancer inhibitors and cures [4].
Plants have many phytochemicals with various bioactivities,
including antioxidant, anti-inflammatory and anticancer
functions. For example, some studies have reported that
extracts from natural products such as fruits, vegetables and
medicinal herbs have positive effects against cancer com-
pared with chemotherapy or recent hormonal treatments
[5]. The family of Piperaceae belonging to superorder Nym-
phaeifloraea, order Piperales [6], comprises about 10 genera
and 2,000 species [7]. The genus Piper (Piperaceae) is largely
distributed in tropical and subtropical regions of the world.
Chemical studies have shown that the genus Piper has many
components including unsaturated amides, flavonoids, lign-
ans, aristolactams, long and short chain esters, terpenes, ster-
oids, prophenylphenols, and alkaloids [8,9]. Some Piper
species are used in folk medicine to treat many diseases,
including fever, jaundice, rheumatism and neuralgia [7]. In
Malaysia, P. sarmentosum is locally known as kaduk and is
commonly used in folk medicine as a carminative. The
leaves and roots of this plant are used for the treatment of
toothaches, fungal dermatitis on the feet, asthmatic cough-
ing and pleurisy [10]. In addition, the plant and its fruits are
used as an expectorant [11].
Previous studies have investigated other biological activi-
ties including the anti-inflammatory effects of Peperomia
pellucida [12] and the antimicrobial effects of Piper anducum
[13,14]. Chloroform extracts from Piper sarmentosum have
also shown considerable antimalarial activity against Plas-
modium falciparum (in vitro) and Plasmodium berghei (in vivo)
[15]. The water extract of the entire plant showed a
hypoglycaemic effect in rats [16], while the methanolic
extract from the leaves of Piper sarmentosum exhibited peak
antioxidant activity [17]. However, the properties of this
plant, and especially its anticarcinogenic activity, have not
yet been investigated. The objective of this study was to
evaluate the anticarcinogenic properties and mode of
action of the Piper sarmentosum ethanolic extract in a
human hepatoma cell line (HepG2). The Chang's liver cell
line was used as a non-malignant cell for cytotoxic activity.
Results and discussion
Cytotoxic activity of P. sarmentosum ethanolic extract 
on cells
In this study, we investigated the effects of a crude eth-
anolic extract from P. sarmentosum in HepG2 and non-
malignant Chang's liver cell lines. In the first part of this
study, the antiproliferative properties of the ethanolic
extract from P. sarmentosum were predetermined using an
MTT assay. The principle of this assay is based on the
reduction of a soluble tetrazolium salt, by mitochondrial
dehydrogenase activity of viable tumour cells, into a solu-
ble coloured formazan product that can be measured
spectrophotometrically after dissolution [18]. The IC50
value was used as a parameter for cytotoxicity.
The criterion for cytotoxicity for the crude extracts, as estab-
lished by the National Cancer Institute (NCI), is an IC50
value lower than 30 μg mL-1 [19]. Figure 1 showed that the
P. sarmentosum ethanolic extract was able to exert antiprolif-
erative effects in the HepG2 cell line tested in dose-depend-
ent manner. The IC50  value of the ethanolic extract for
HepG2 cells viability was 12.5 μg mL-1 after exposure for 72
hours (Figure 1). Our results show that the normal counter-
part cells (non-malignant Chang's liver) treated with 200 μg
mL-1 of ethanolic extract still retained > 50% viable cells, i.e.,
55.6% viability. On the other hand, IC50 values for the eth-
anolic extract in non-malignant Chang's liver cells were more
than 30 μg mL-1 (Figure 1). Therefore, P. sarmentosum eth-
anolic extract predetermination by MTT assay induced cyto-
toxicity activity in the hepatoma cell line (HepG2), but not
in the non-malignant cell line (Chang's liver).
Comparatively, tamoxifen, a drug with anti-oestrogenic
activity, was used in this study as a positive control.
Tamoxifen imposed an inhibitory effect in the HepG2 cell
line with an IC50 value of 3 μg mL-1 and in the non-malig-
nant Chang's liver cell line with a value of 18.6 μg mL-
1(Figure 2). Therefore, tamoxifen induced cytotoxic activ-
ity in both carcinoma (HepG2) and non-carcinoma (non-
malignant Chang's liver) cells. Both cells induced IC50
below 30 μg mL-1 and were thus considered to induce
cytotoxic activity to the treated cells, as recommended by
National Cancer Institute (NCI) [19]. NCI recommended
that any extract generates IC50 below than 30 μg mL-1 is
considered possess cytotoxic activity. As a result, MTT
assay analysis showed that the ethanolic extract of P. sar-
mentosum induced cytotoxic activity in HepG2 cells, but
not in the non-malignant Chang's liver cells. In contrast,
an anticarcinogenic drug (tamoxifen) induced cytotoxic
activity in hepatocellular carcinoma, HepG2 and non-
malignant Chang's liver cell lines.
Morphological observation
Light microscopic observation of the P. sarmentosum eth-
anolic extract-treated HepG2 cell line after 72 hours of
exposure showed typical morphological features ofCancer Cell International 2009, 9:6 http://www.cancerci.com/content/9/1/6
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apoptosis. The characterisation of morphological changes
observed were reduction in cell volume, cell shrinkage,
reduction in chromatin condensation and formation of
cytoplasmic blebs [20]. Figure 3B shows that the HepG2
cells treated with ethanolic extract at 12.5 μg mL-1were
changed into round shapes as compared to untreated
HepG2 cells (Figure 3A). The untreated cells (HepG2) also
showed a high confluency of monolayer cells (Figure 3A)
compared to ethanolic extract-treated cells, which showed
a reduction in cell volume and cell shrinkage (Figure 3B).
Figure 3C shows that the morphology of the untreated non-
malignant Chang's liver cell line is a confluent monolayer.
The non-malignant Chang's liver cell line was then treated
with 12.5 μg mL-1 of P. sarmentosum ethanolic extract. After
72 hours of incubation, the morphology of the treated non-
malignant Chang's liver cell line (Figure 3D) showed simi-
lar morphology to that untreated non-malignant Chang's
liver cell line (Figure 3C).
Morphological observation by May-Grunwald Giemsa's 
staining
Ethanolic extracts from P. sarmentosum can induce apop-
tosis in HepG2 cells, as proven using May-Grunwald-
Giemsa's staining (Figure 4). The apoptotic morphologi-
cal pictures clearly show the appearance of apoptotic bod-
ies (indicated as white arrow) when using an inverted
microscope at 100× actual magnification. Marked mor-
phological changes of the apoptotic cells are represented
by apoptotic bodies (indicated as white arrow), which are
easily determined by May-Grunwald-Giemsa's staining
(Figure 4A, C and 4E). These apoptotic cells can be seen
when the cells are exposed to 12.5 μg mL-1 of the ethanolic
extract for 24, 48 and 72 hours.
Apoptotic Index (AI)
The apoptotic index (AI) was calculated to confirm that
ethanolic-treated cell death was via apoptosis. AI is
described as the percentage of apoptotic cells and apop-
totic bodies within the overall population of cells [21]. An
apoptotic index was determined as the percentage of
apoptotic cells from at least 400 counted cells under
observation using an inverted microscope. The statistical
differences between the control group and treated group
(1% DMSO, 24 hours, 48 hours and 72 hours) were ana-
lysed using ANOVA, and p values less than 0.05 were con-
sidered as significant. The percentages of apoptotic cells
after treatment were increased in a time-dependent man-
ner with less than 50% at 24 hours, more than 50% at 48
hours and even higher at 72 hours. Untreated cells are rep-
resented as the control, i.e., the HepG2 cell line cultured
in complete media for 72 hours. The control cells showed
that only 4% of these cell deaths produced a typical mor-
MTT assaying of the P. sarmentosum ethanolic extract in HepG2 and non-malignant Chang's liver cells Figure 1
MTT assaying of the P. sarmentosum ethanolic extract in HepG2 and non-malignant Chang's liver cells. Both 
cells were treated at various concentrations, i.e., 1.56–200 μg mL-1. The IC50 value for HepG2 was 12.5 μg mL-1, while the IC50 
value for non-malignant Chang's liver cells was > 30 μg mL-1. Each data point represents values from three independent exper-
iments (n = 3).
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phological apoptotic feature (Figure 5). On the other
hand, cells treated with 1% DMSO (negative control) for
72 hours produced only 8% cell death and showed no sig-
nificant difference (p > 0.05) when compared to untreated
cells (control). In contrast, Figure 5 also showed that the
AI percentage of HepG2 cells increased significantly (p <
0.05) when the HepG2 cell line was treated with 12.5 μg
mL-1 of ethanolic extract from P. sarmentosum at 24 hours
compared to the control. The AI percentage of the HepG2
cell line also continued to increase significantly (p < 0.05)
when the HepG2 cell line was treated with ethanolic
extracts at 48 and 72 hours compared to the control (Fig-
ure 5). This observation indicated that the apoptotic activ-
ity was gradually increased when the ethanolic extract was
incubated longer in carcinoma HepG2 cells.
Morphological observation by acridine orange and 
ethidium bromide (AO/EB) staining
Staining cells with fluorescent dyes, including acridine
orange and ethidium bromide, is used in evaluating the
nuclear morphology of apoptotic cells. To corroborate
that apoptosis has been induced by P. sarmentosum eth-
anolic plant extract, HepG2 cells were analysed in the
presence of acridine orange and ethidium bromide stain-
ing (AO/EB staining). Acridine orange is a vital dye that
will stain both live and dead cells, whereas ethidium bro-
mide will stain only those cells that have lost their mem-
brane integrity [22]. Three different concentrations were
chosen based on the IC50 values determined by MTT assay,
which were 10, 12 and 14 μg mL-1. As a control, HepG2
cells were cultured in complete media and stained with
AO/EB (Figure 6A). The figure shows that the ethanolic
extract from P. sarmentosum induced apoptosis after 72
hours incubation at all concentrations of plant extract
tested. Cells stained green represent viable cells, whereas
yellow staining represented early apoptotic cells, and red-
dish or orange staining represents late apoptotic cells. As
shown in Figure 6B, HepG2 cells treated with 10 μg mL-1
of ethanolic extract showed changes in cellular morphol-
ogy, including chromatin condensation, membrane bleb-
bing, and fragmented nuclei. On the other hand, Figures
6C and 6D show similar features for cells treated with 10
μg mL-1 of ethanolic extract (Figure 6B), but with extra fea-
tures of late stage apoptotic activity with apoptotic bodies
when HepG2 cells were treated with 12 μg mL-1 and 14 μg
mL-1 of ethanolic extract from P. sarmentosum. Therefore,
using the AO/EB staining procedure, the morphological
features of a hepatoma cell line in apoptosis were dose
dependent, i.e., a stronger apoptosis signal was induced
with higher concentrations of the respective extract.
Determination of intrinsic apoptosis by DNA 
fragmentation
DNA fragmentation occurs in cells that produce intrinsic
apoptosis activity when induced by a variety of agents.
This cleavage produces ladders of DNA fragments that are
MTT assaying of tamoxifen in HepG2 and non-malignant Chang's liver cells Figure 2
MTT assaying of tamoxifen in HepG2 and non-malignant Chang's liver cells. Both cells were treated at various con-
centrations (1.56–25 μg mL-1). The IC50 value for HepG2 is 3 μg mL-1 and 18.6 μg mL-1 for non-malignant Chang's liver cells. 
Each data point represent values from three independent experiments (n = 3).
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the size of integer multiples of a nucleosome length (180–
200 bp) [23]. The DNA fragmentation is initiated by cas-
pase 3 activation of inactive CAD (caspase activated deox-
yribonuclease) through removal of its inhibitors, i.e.,
ICAD [6]. As a biochemical hallmark of intrinsic apop-
totic cell death, DNA fragmentation was used to deter-
mine whether the antiproliferative effect of P. sarmentosum
ethanolic extract on cells acts through the respective apop-
tosis pathway [24]. As shown in Figure 7, the treatment of
HepG2 cells with ethanolic extract resulted in the induc-
tion of intrinsic apoptosis activity at concentrations as low
as 10 μg mL-1. HepG2 cells were treated with three differ-
ent concentrations of ethanolic extract (10, 12 and 14 μg
mL-1) based on the IC50 that was predetermined by MTT
assay. HepG2 cells treated with different concentrations of
ethanolic extract (Lane 1–3; Figure 7) for 72 hours
showed typical features of DNA laddering on an agarose
gel, whereas untreated cells produced intact genomes
(Lane 5; Figure 8). In contrast, the non-malignant Chang's
liver cell line when treated with the various concentra-
tions of ethanolic extract (Lane 1–3; Figure 8) produced
similar genomic DNA features as in untreated non-malig-
nant Chang's liver (Lane 4; Figure 8) and HepG2 (Lane 5;
Figure 8) cell lines. Therefore, the ethanolic extract at a
concentration as low as 10 μg mL-1 can induce nucleo-
somal DNA fragmentation of HepG2 due to intrinsic
apoptosis processes, but not in the non-malignant
Chang's liver cell line. In this study, the reason of using
"HepG2" and "Chang" liver cells because HepG2 are the
model of hepatocellular carcinoma while Chang liver cells
are considered as an in vitro model of non-malignant or
non-tumor liver cells. This is based on other studies such
as Antonin et al. and Teck et al. stated that Chang as non-
malignant cells [25,26].
Morphological studies by inverted microscope at actual mag- nification 100× Figure 3
Morphological studies by inverted microscope at 
actual magnification 100×. HepG2 and non-malignant 
Chang's liver cell line were treated without (A, C) and with 
12.5 μg mL-1 of P. sarmentosum ethanolic extract (B, D) for 72 
hours. Both types of treatment (C and D) produced similar 
cellular morphology and antiproliferative effect. However, in 
HepG2 cells, the confluency appeared to be reduced from 
90% in untreated cells to 10% in treated cells. Similar cellular 
morphology was observed in three independent experiments 
(n = 3).
Morphological observation with May-Grunwald-Giemsa's  staining at actual magnification 100× Figure 4
Morphological observation with May-Grunwald-
Giemsa's staining at actual magnification 100×. 
HepG2 cells were treated for 24 (A), 48 (C) and 72 (E) hours 
with 12.5 μg mL-1 of P. sarmentosum ethanolic extract while 
untreated HepG2 cells were grow in complete medium for 
24 (B), 48 (D) and 72 (F) hours. The white arrows indicated 
apoptotic bodies. The figures shown are representative of 
three independent experiments (n = 3).Cancer Cell International 2009, 9:6 http://www.cancerci.com/content/9/1/6
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Conclusion
P. sarmentosum ethanolic extract showed a profound effect
on a human hepatoma cell line (HepG2) by exhibiting its
cytotoxicity towards this cell, i.e., IC50 12.5 μg mL-1. In
contrast, the respective extract did not induced a cytotoxic
effect in a non-malignant cell line (Chang's liver cell line),
i.e., IC50 > 30 μg mL-1. Moreover, this ethanolic extract,
through morphological analysis using May-Grunwald-
Giemsa's and AO/EB staining procedures, showed that the
extract was able to trigger cell death through apoptosis.
Our observation using AO/EB staining also showed that
the extract was able to induce apoptotic activity at concen-
trations as low as 10 μg mL-1. In addition, molecular anal-
ysis through DNA fragmentation revealed that the cell
death mode of action occurred by an intrinsic apoptosis
pathway.
Methods
Plant Materials
Fresh plant materials were collected from the Forest
Research Institute of Malaysia (FRIM), Kuala Lumpur,
Malaysia. Plant extraction was conducted at the Microbi-
ology Laboratory, Faculty of Applied Science, Universiti
Teknologi MARA (UiTM) from July 2006 to December
2006. The anticarcinogenic activity of HepG2 and non-
malignant Chang's liver cell lines was conducted at Labo-
ratory 4172 and 4176, School of Bioscience and Biotech-
nology, Faculty of Science and Technology, Universiti
Kebangsaan Malaysia (UKM) from January 2007 to Octo-
ber 2008.
Preparation of plant materials
Plant materials were dried in an oven at 50°C and then
soaked three times in ethanol. The extracts were then fil-
tered and concentrated under reduced pressure using a
rotary evaporator (Buchi V-500) at 40°C. The concen-
trated ethanolic extract was dissolved in 1% DMSO to
generate various concentrations of extract (1.56–200 μg
mL-1) for further analyses.
Cell culture
The human hepatoma (HepG2) and non-malignant
Chang's liver cell lines were kindly provided by Dr. Fadi-
lah Rajab of the Universiti Kebangsaan Malaysia (UKM).
Percentages of HepG2 cell death via apoptosis after treatment with ethanolic extract from P. sarmentosum Figure 5
Percentages of HepG2 cell death via apoptosis after treatment with ethanolic extract from P. sarmentosum. 
The percentages of HepG2 cell death via apoptosis increased significantly in a time-dependent manner. p < 0.05 represents the 
statistically significant difference between the control and treated group (1% DMSO, 24–72 hours of incubation in 12.5 μg mL-
1 of ethanolic extract). *Represents significant results (p < 0.05) using ANOVA statistical analysis when the treated group was 
compared with the control.
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Both cells were cultured in RPMI 1640 (Flowlab) supple-
mented with 10% foetal bovine serum (FBS; Gibco), pen-
icillin (50 U mL-1) and streptomycin (50 μg mL-1)
(Gibco). Cells were maintained in humidified air with 5%
CO2 at 37°C. Cells were harvested using 0.25% trypsin
(Hyclone) when they were 70–80% confluent in culture.
MTT assay
Briefly, 200 μL of cells (1 × 104 cells) were seeded into 96-
well plates and incubated overnight. The following day,
cells were then treated with 20 μL of various concentra-
tions of extract (1.56–200 μg mL-1) and tamoxifen (posi-
tive control) before further incubation for 72 hours. At the
end of this incubation, 20 μL of MTT (Sigma) (2 mg mL-1
in PBS) was added to each well and incubated for another
4 hours at 37°C. The formazan crystals were dissolved in
100 μL dimethylsulphoxide (DMSO) and the absorbance
was determined at 540 nm using a multi-plate reader
(BIO-RAD model 680). The absorbance value that was
determined for cells cultured in complete media without
plant extract was based on 100% viable cells. Each con-
centration of the extract was assayed in triplicate.
Cell observation using an inverted microscope
HepG2 cell lines were grown in 6-well plates and treated
with P. sarmentosum ethanolic extract. The cells were then
washed with 1× Phosphate Buffer Saline (PBS) (Sigma).
Morphological and confluency changes in the cells in
both the treated group (12.5 μg mL-1 of ethanolic treated-
cells incubated for 24, 48 and 72 hours and 1% DMSO
treated-cells for 72 hours) and untreated group were
observed using an inverted microscope (Nikon TMS).
Apoptosis analysis
Giemsa staining
Briefly, the HepG2 cell line was seeded at 1 × 105 cells/well
in 6-well plates (BD Labware, England), and the plates
were then incubated overnight at 37°C. After incubation,
ethanolic extracts of various concentrations (10, 12 and
14 μg mL-1) were added and incubated for an additional
24 hours. The plates were washed with 1× Phosphate
Morphological observation with acridine orange and ethid- ium bromide (AO/EB) staining at actual magnification 400× Figure 6
Morphological observation with acridine orange and 
ethidium bromide (AO/EB) staining at actual magni-
fication 400×. HepG2 cells were treated without (A) and 
with P. sarmentosum ethanolic extract, 10 μg mL-1 (B), 12 μg 
mL-1 (C) and 14 μg mL-1 (D) for 72 hours. Dashed arrow 
indicated cells with chromatin condensation; rounded dotted 
arrow indicated cells with fragmented nuclei; dashed dotted 
arrow indicated cells with membrane blebbing and full white 
arrow indicated the presence of apoptotic bodies. Each 
experiment was performed in triplicate (n = 3) and gener-
ated similar morphological features.
Gel electrophoresis of DNA genomes extracted from vari- ous HepG2 cells following treatment Figure 7
Gel electrophoresis of DNA genomes extracted from 
various HepG2 cells following treatment. Cells were 
incubated with various concentrations of ethanolic extract 
for 72 hours. DNA fragments were separated using 1.5% aga-
rose gel electrophoresis and visualised under UV light after 
staining with ethidium bromide. M: 100 bp DNA ladder 
marker, lane 1: HepG2 treated with 10 μg mL-1 of P. sarmen-
tosum ethanolic extract, lane 2: HepG2 treated with 12 μg 
mL-1 of P. sarmentosum ethanolic extract and lane 3: HepG2 
treated with 14 μg mL-1 of P. sarmentosum ethanolic extract. 
Each experiment was performed in triplicate (n = 3).Cancer Cell International 2009, 9:6 http://www.cancerci.com/content/9/1/6
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Buffer Saline (PBS), and the cells were stained with May-
Grundwald (BDH Chemical Ltd) for 4 minutes. The slides
were then rinsed with sterile water and flooded with
freshly prepared Giemsa's stain solution (BDH Chemical
Ltd) for 6 minutes. Dyestuff was discarded and rinsed
again three times with sterile water. Morphological
changes were examined using an inverted microscopy
(Nikon, TMS) with 100× actual magnification.
Acridine orange and ethidium bromide staining (AO/EB staining)
For this purpose, cells were seeded in 6-well plates for 24
hours and then treated with different concentration
ranges (10, 12 and 14 μg mL-1) for 72 hours. After harvest-
ing by trypsinisation, cells were washed with 1× PBS once.
Twenty-five microlitres of the cell suspension was then
mixed with 1 μL of the dye mixture, containing 100 mg
mL-1 of acridine orange (Sigma) and 100 mg mL-1 of
ethidium bromide (Sigma) in 1× PBS. After staining, cells
were visualised immediately under a fluorescence micro-
scope (Leica DM 2500).
Intrinsic apoptosis as determined by DNA fragmentation
Cells were lysed with lysis buffer (10 mM Tris-HCL, 5 mM
EDTA, 200 mM NaCl, 0.2% SDS) and incubated at 60°C
for 5 minutes. The sample was digested with 2.5 μL of pro-
teinase K (more than 3 U μL-1) (Sigma) and 5 μL of RNase
A (1 U μL-1) (Fermentas) and was further incubated at
60°C for 1 hour. After this, 250 μL of 5 M NaCl was added
and mixed and then incubated on ice for 5 minutes to pre-
cipitate proteins. Cells were then centrifuged for 15 min-
utes at 10,000 rpm and the supernatant was transferred to
a fresh tube, to which an equal volume of isopropanol
was added to precipitate the DNA, and the sample was
centrifuged for 10 minutes at 10,000 rpm. The superna-
tants were then discarded, and the pellets were washed
with 70% cold ethanol. DNA samples were electro-
phoresed on a 1.5% agarose gel for 1 hour and 30 minutes
at 70 V. Finally, the gel was examined under UV light fol-
lowing ethidium bromide staining to determine apoptotic
DNA fragmentation.
Data analysis
The analysis of variance (ANOVA) was used to determine
differences between treated and control groups using
Microsoft™ Excel 2007 software. p values less than 0.05 (p
< 0.05) were considered statistically significant.
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